-
These 25 cos in T+0 from Thursday
The move will bring cost and time efficiency, transparency in charges to investors and strengthen risk management at clearing corporations
-
How India Inc performed in Q3 FY24?
Which sectors performed well and which ones disappointed? Here's a look at the Q3 results...
-
Will Pharma Sector Get its Mojo Back?
Despite this challenging macro environment, we remain optimistic about the growth outlook of the Indian pharmaceutical companies
-
The changing face of Indian promoters
The way to power no longer lies on the properties of the urban, upper-class, pedigreed elite. It belongs just as much to the middle-class, small-town
-
Axis Bank, Bajaj Finance, Cipla to react to September quarterly results
Firstsource Solutions announced it has partnered with Eco-Mail, a leading SaaS provider that transforms physical mail assets into digital assets.
-
Stay away from IT, metals in the near term: Gautam Shah, Goldilocks
"While India continues to be one of the better performers in global markets, the short term charts look overbought"
-
Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India
Moderna through a separate communication has informed that the US government has agreed to donate a certain number of doses to the Indian government.
-
Here’s how the Money9 Covid25 index performed this week
Since March 24, 2020, Money9 Covid25 Index has outperformed both Nifty 50 as well as Nifty Pharma indices with a big margin
-
Names of top brands: Did you know these quirky facts?
Here are the interesting facts behind the 'names' of top Indian companies
-
Norms for clearing foreign-made Covid-19 vaccines eased by DCGI
These exemptions have been made in light of the huge vaccination requirements in India in the wake of the recent surge of Covid-19 cases.
